ScholarGate
Assistant

Mild Cognitive Impairment

Mild cognitive impairment (MCI) is an intermediate state between the cognitive changes of normal ageing and the more severe deficits of dementia. People with MCI show measurable cognitive decline beyond what is expected for age, yet they remain largely independent in everyday activities, which distinguishes the condition from dementia.

Find Topic with PaperMindSoonFind papers & topics
Tools & resources
Download slides
Learn & explore
VideoSoon

Definition

Mild cognitive impairment is a syndrome of acquired decline in one or more cognitive domains that is greater than expected for a person's age and education but does not significantly interfere with independence in daily activities, and so does not meet criteria for dementia.

Scope

This topic covers the definition of MCI, its amnestic and non-amnestic subtypes, the criterion of preserved daily function that separates it from dementia, and its variable prognosis, including progression to dementia, stability, or reversion to normal cognition. It is a reference entry and does not provide diagnostic protocols or treatment advice.

Core questions

  • What distinguishes MCI from normal cognitive ageing and from dementia?
  • How do amnestic and non-amnestic subtypes differ?
  • What is the likelihood of progression to dementia versus stability or reversion?
  • How does MCI relate to underlying Alzheimer and non-Alzheimer pathologies?

Key concepts

  • Intermediate stage on the cognitive continuum
  • Preserved functional independence as the defining boundary from dementia
  • Amnestic versus non-amnestic subtypes
  • Single- versus multiple-domain involvement
  • MCI due to Alzheimer's disease
  • Heterogeneous prognosis (progression, stability, reversion)

Mechanisms

MCI is a clinical syndrome rather than a single disease and can reflect early stages of several underlying pathologies. The amnestic form, with prominent memory impairment, frequently reflects early Alzheimer disease pathology, and consensus criteria describe how biomarkers of amyloid and neuronal injury can support a designation of MCI due to Alzheimer's disease. Non-amnestic forms, affecting domains such as language, attention, or executive and visuospatial function, may reflect vascular, Lewy body, frontotemporal, or other processes.

Clinical relevance

MCI marks a stage at which cognitive change is detectable but independence is preserved, making it a focus for monitoring, characterisation of underlying cause, and identification of contributing factors. This entry describes the concept and its prognosis for educational purposes and does not direct individual evaluation or care.

Epidemiology

MCI is common in older adults and its prevalence increases with age. Outcomes are heterogeneous: a substantial proportion of people with MCI progress to dementia over subsequent years, while others remain stable and some revert to normal cognition, so MCI status is not deterministic of dementia.

Evidence & guidelines

The condition is framed by the National Institute on Aging-Alzheimer's Association recommendations on MCI due to Alzheimer's disease and by clinical reviews such as Petersen (2011). These are referenced to orient the reader and not to direct management.

History

The notion of an intermediate state between normal ageing and dementia was crystallised in the 1990s and 2000s, with Petersen and colleagues defining and refining MCI criteria. In 2011 the National Institute on Aging-Alzheimer's Association workgroups formalised criteria for MCI due to Alzheimer's disease, incorporating biomarkers and embedding MCI in a continuum model of disease.

Debates

How stable and reproducible is the MCI category?
Because MCI is heterogeneous and a meaningful fraction of cases revert to normal cognition, there is ongoing discussion about diagnostic thresholds, subtyping, and how reliably MCI predicts later dementia.

Key figures

  • Ronald Petersen
  • Marilyn Albert

Related topics

Seminal works

  • petersen-2011
  • albert-2011

Frequently asked questions

Does mild cognitive impairment always progress to dementia?
No. MCI has a variable course: many people progress to dementia over time, but others remain stable, and some return to normal cognition, so it is not the same as early dementia.
How is MCI different from dementia?
Both involve measurable cognitive decline, but in MCI the person remains essentially independent in daily activities, whereas dementia is defined by cognitive loss severe enough to impair that independence.

Methods for this concept

Related concepts